{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:11:44Z","timestamp":1789053104829,"version":"build-2803163510"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10620-026-10049-x","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:44:12Z","timestamp":1781711052000},"page":"5228-5246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update on Diet and Nutritional Therapies in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"71","author":[{"given":"Mark R.","family":"Baniqued","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa M.","family":"Parian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"10049_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0884533616674492","volume":"32","author":"BN Limketkai","year":"2017","unstructured":"Limketkai BN, Mullin GE, Limsui D, Parian AM. Role of vitamin D in inflammatory bowel disease. Nutrition in Clinical Practice 2017;32:337\u2013345. https:\/\/doi.org\/10.1177\/0884533616674492.","journal-title":"Nutrition in Clinical Practice"},{"key":"10049_CR2","doi-asserted-by":"publisher","first-page":"7778","DOI":"10.3390\/nu16060778","volume":"16","author":"S Rau","year":"2024","unstructured":"Rau S, Gregg A, Yaceczko S, Limketkai B. Prebiotics and probiotics for gastrointestinal disorders. Nutrients 2024;16:7778. https:\/\/doi.org\/10.3390\/nu16060778.","journal-title":"Nutrients"},{"key":"10049_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013;504:446\u2013450. https:\/\/doi.org\/10.1038\/nature12721.","journal-title":"Nature"},{"key":"10049_CR4","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","volume":"52","author":"LE Willemsen","year":"2003","unstructured":"Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut 2003;52:1442\u20131447. https:\/\/doi.org\/10.1136\/gut.52.10.1442.","journal-title":"Gut"},{"key":"10049_CR5","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009;461:1282\u20131286. https:\/\/doi.org\/10.1038\/nature08530.","journal-title":"Nature"},{"key":"10049_CR6","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.4049\/jimmunol.0900063","volume":"183","author":"C Sina","year":"2009","unstructured":"Sina C, Gavrilova O, F\u00f6rster M et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. Journal of Immunology 2009;183:7514\u20137522. https:\/\/doi.org\/10.4049\/jimmunol.0900063.","journal-title":"Journal of Immunology"},{"key":"10049_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/1751-2980.12910","volume":"21","author":"T Li","year":"2020","unstructured":"Li T, Qiu Y, Yang HS et al. Systematic review and meta-analysis: Association of a pre-illness Western dietary pattern with the risk of developing inflammatory bowel disease. Journal of Digestive Diseases 2020;21:362\u2013371. https:\/\/doi.org\/10.1111\/1751-2980.12910.","journal-title":"Journal of Digestive Diseases"},{"key":"10049_CR8","doi-asserted-by":"publisher","first-page":"e1323","DOI":"10.1016\/j.cgh.2021.08.031","volume":"20","author":"CH Lo","year":"2022","unstructured":"Lo CH, Khandpur N, Rossato SL et al. Ultra-processed foods and risk of Crohn\u2019s disease and ulcerative colitis: A prospective cohort study. Clinical Gastroenterology and Hepatology 2022;20:e1323\u2013e1337. https:\/\/doi.org\/10.1016\/j.cgh.2021.08.031.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR9","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/gutjnl-2019-319505","volume":"69","author":"H Khalili","year":"2020","unstructured":"Khalili H, H\u00e5kansson N, Chan SS et al. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn\u2019s disease: Results from two large prospective cohort studies. Gut 2020;69:1637\u20131644. https:\/\/doi.org\/10.1136\/gutjnl-2019-319505.","journal-title":"Gut"},{"key":"10049_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/01.MIB.0000206540.38834.8c","volume":"12","author":"V Nerich","year":"2006","unstructured":"Nerich V, Monnet E, Etienne A et al. Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data. Inflammatory Bowel Diseases 2006;12:218\u2013226. https:\/\/doi.org\/10.1097\/01.MIB.0000206540.38834.8c.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR11","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.cgh.2022.11.026","volume":"21","author":"BN Limketkai","year":"2023","unstructured":"Limketkai BN, Godoy-Brewer G, Parian AM et al. Dietary interventions for the treatment of inflammatory bowel diseases: An updated systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 2023;21:2508-2525.e10. https:\/\/doi.org\/10.1016\/j.cgh.2022.11.026.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1136\/gut.26.10.989","volume":"26","author":"S Levenstein","year":"1985","unstructured":"Levenstein S, Prantera C, Luzi C, D\u2019Ubaldi A. Low residue or normal diet in Crohn\u2019s disease: A prospective controlled study in Italian patients. Gut 1985;26:989\u2013993. https:\/\/doi.org\/10.1136\/gut.26.10.989.","journal-title":"Gut"},{"key":"10049_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/bmj.295.6597.517","volume":"295","author":"JK Ritchie","year":"1987","unstructured":"Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre-rich diet in Crohn\u2019s disease. BMJ (Clinical Research Edition) 1987;295:517\u2013520. https:\/\/doi.org\/10.1136\/bmj.295.6597.517.","journal-title":"BMJ (Clinical Research Edition)"},{"key":"10049_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.clnu.2022.12.004","volume":"42","author":"SC Bischoff","year":"2023","unstructured":"Bischoff SC, Bager P, Escher J et al. ESPEN guideline on clinical nutrition in inflammatory bowel disease. Clinical Nutrition 2023;42:352\u2013379. https:\/\/doi.org\/10.1016\/j.clnu.2022.12.004.","journal-title":"Clinical Nutrition"},{"key":"10049_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","volume":"166","author":"JG Hashash","year":"2024","unstructured":"Hashash JG, Elkins J, Lewis JD, Binion DG. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: Expert review. Gastroenterology 2024;166:521\u2013532. https:\/\/doi.org\/10.1053\/j.gastro.2023.11.303.","journal-title":"Gastroenterology"},{"key":"10049_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5009\/gnl230093","volume":"18","author":"D Xu","year":"2024","unstructured":"Xu D, Peng Z, Li Y, Hou Q, Peng Y, Liu X. Progress and clinical applications of Crohn\u2019s disease exclusion diet in Crohn\u2019s disease. Gut and Liver 2024;18:404\u2013413. https:\/\/doi.org\/10.5009\/gnl230093.","journal-title":"Gut and Liver"},{"key":"10049_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1097\/MIB.0000000000000110","volume":"20","author":"R Sigall-Boneh","year":"2014","unstructured":"Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn\u2019s disease exclusion diet is effective for induction of remission in children and young adults with Crohn\u2019s disease. Inflammatory Bowel Diseases 2014;20:1353\u20131360. https:\/\/doi.org\/10.1097\/MIB.0000000000000110.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/ecco-jcc\/jjx071","volume":"11","author":"R Sigall Boneh","year":"2017","unstructured":"Sigall Boneh R, Sarbagili Shabat C, Yanai H et al. Dietary therapy with the Crohn\u2019s disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy. Journal of Crohn\u2019s and Colitis 2017;11:1205\u20131212. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx071.","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10049_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","volume":"157","author":"A Levine","year":"2019","unstructured":"Levine A, Wine E, Assa A et al. Crohn\u2019s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology 2019;157:440-450.e8. https:\/\/doi.org\/10.1053\/j.gastro.2019.04.021.","journal-title":"Gastroenterology"},{"key":"10049_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.12.006","volume-title":"Modified Crohn\u2019s disease exclusion diet maintains remission in pediatric Crohn\u2019s disease: Randomized controlled trial","author":"R Sigall Boneh","year":"2024","unstructured":"Sigall Boneh R, Navas-L\u00f3pez VM, Hussey S et al. Modified Crohn\u2019s disease exclusion diet maintains remission in pediatric Crohn\u2019s disease: Randomized controlled trial. Clinical Gastroenterology and Hepatology: Advance online publication; 2024. https:\/\/doi.org\/10.1016\/j.cgh.2024.12.006."},{"key":"10049_CR21","doi-asserted-by":"publisher","first-page":"902","DOI":"10.14309\/ajg.0000000000001800","volume":"117","author":"HC Kaplan","year":"2022","unstructured":"Kaplan HC, Opipari-Arrigan L, Yang J et al. Personalized research on diet in ulcerative colitis and Crohn\u2019s disease: A series of N-of-1 diet trials. American Journal of Gastroenterology 2022;117:902\u2013917. https:\/\/doi.org\/10.14309\/ajg.0000000000001800.","journal-title":"American Journal of Gastroenterology"},{"key":"10049_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000000449","volume":"59","author":"SA Cohen","year":"2014","unstructured":"Cohen SA, Gold BD, Oliva S et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition 2014;59:516\u2013521. https:\/\/doi.org\/10.1097\/MPG.0000000000000449.","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10049_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.nut.2015.08.025","volume":"32","author":"C Obih","year":"2016","unstructured":"Obih C, Wahbeh G, Lee D et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition 2016;32:418\u2013425. https:\/\/doi.org\/10.1016\/j.nut.2015.08.025.","journal-title":"Nutrition"},{"key":"10049_CR24","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jand.2015.04.016","volume":"115","author":"S Kakodkar","year":"2015","unstructured":"Kakodkar S, Farooqui AJ, Mikolaitis SL, Mutlu EA. The specific carbohydrate diet for inflammatory bowel disease: A case series. Journal of the Academy of Nutrition and Dietetics 2015;115:1226\u20131232. https:\/\/doi.org\/10.1016\/j.jand.2015.04.016.","journal-title":"Journal of the Academy of Nutrition and Dietetics"},{"key":"10049_CR25","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3748\/wjg.v22.i6.2111","volume":"22","author":"JC Burgis","year":"2016","unstructured":"Burgis JC, Nguyen K, Park KT, Cox K. Response to strict and liberalized specific carbohydrate diet in pediatric Crohn\u2019s disease. World Journal of Gastroenterology 2016;22:2111\u20132117. https:\/\/doi.org\/10.3748\/wjg.v22.i6.2111.","journal-title":"World Journal of Gastroenterology"},{"key":"10049_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MPG.0000000000001613","volume":"65","author":"K Braly","year":"2017","unstructured":"Braly K, Williamson N, Shaffer ML et al. Nutritional adequacy of the specific carbohydrate diet in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2017;65:533\u2013538. https:\/\/doi.org\/10.1097\/MPG.0000000000001613.","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10049_CR27","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1053\/j.gastro.2021.05.047","volume":"161","author":"JD Lewis","year":"2021","unstructured":"Lewis JD, Sandler RS, Brotherton C et al. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn\u2019s disease. Gastroenterology 2021;161:837-852.e9. https:\/\/doi.org\/10.1053\/j.gastro.2021.05.047.","journal-title":"Gastroenterology"},{"key":"10049_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000535540","volume":"42","author":"R Sigall Boneh","year":"2024","unstructured":"Sigall Boneh R, Assa A, Lev-Tzion R et al. Adherence to the Mediterranean diet is associated with decreased fecal calprotectin levels in children with Crohn\u2019s disease in clinical remission under biological therapy. Digestive Diseases 2024;42:199\u2013210. https:\/\/doi.org\/10.1159\/000535540.","journal-title":"Digestive Diseases"},{"key":"10049_CR29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3390\/nu16111557","volume":"16","author":"M Cadoni","year":"2024","unstructured":"Cadoni M, Favale A, Piras R et al. Adherence to Mediterranean diet and diet quality in patients with inflammatory bowel disease: A single-center, observational, case-control study. Nutrients 2024;16:1557. https:\/\/doi.org\/10.3390\/nu16111557.","journal-title":"Nutrients"},{"key":"10049_CR30","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/nu16101504","volume":"16","author":"\u00d6 Erol Do\u011fan","year":"2024","unstructured":"Erol Do\u011fan \u00d6, Karaca \u00c7elik KE, Ba\u015f M, Alan EH, \u00c7a\u011f\u0131n YF. Effects of Mediterranean diet, curcumin, and resveratrol on mild-to-moderate active ulcerative colitis: A multicenter randomized clinical trial. Nutrients 2024;16:1504. https:\/\/doi.org\/10.3390\/nu16101504.","journal-title":"Nutrients"},{"key":"10049_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ibd\/izae062","volume":"31","author":"S Garc\u00eda-Mateo","year":"2025","unstructured":"Garc\u00eda-Mateo S, Mart\u00ednez-Dom\u00ednguez SJ, Gargallo-Puyuelo CJ et al. Healthy lifestyle is a protective factor from moderate and severe relapses and steroid use in inflammatory bowel disease: A prospective cohort study. Inflammatory Bowel Diseases 2025;31:95\u2013104. https:\/\/doi.org\/10.1093\/ibd\/izae062.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR32","doi-asserted-by":"publisher","first-page":"jjaf122","DOI":"10.1093\/ecco-jcc\/jjaf122","volume":"19","author":"V Svolos","year":"2025","unstructured":"Svolos V, Gordon H, Lomer MCE et al. European Crohn\u2019s and Colitis Organisation consensus on dietary management of inflammatory bowel disease. Journal of Crohn\u2019s & Colitis 2025;19:jjaf122. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf122.","journal-title":"Journal of Crohn\u2019s & Colitis"},{"key":"10049_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5217\/ir.2020.00035","volume":"19","author":"NH Shafiee","year":"2021","unstructured":"Shafiee NH, Manaf ZA, Mokhtar NM, Raja Ali RA. Anti-inflammatory diet and inflammatory bowel disease: What clinicians and patients should know? Intestinal Research 2021;19:171\u2013185. https:\/\/doi.org\/10.5217\/ir.2020.00035.","journal-title":"Intestinal Research"},{"key":"10049_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2891-13-5","volume":"13","author":"BC Olendzki","year":"2014","unstructured":"Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: A case series report. Nutrition Journal 2014;13:5. https:\/\/doi.org\/10.1186\/1475-2891-13-5.","journal-title":"Nutrition Journal"},{"key":"10049_CR35","doi-asserted-by":"publisher","first-page":"2046244","DOI":"10.1080\/19490976.2022.2046244","volume":"14","author":"B Olendzki","year":"2022","unstructured":"Olendzki B, Bucci V, Cawley C et al. Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study. Gut Microbes 2022;14:2046244. https:\/\/doi.org\/10.1080\/19490976.2022.2046244.","journal-title":"Gut Microbes"},{"key":"10049_CR36","doi-asserted-by":"publisher","first-page":"otz019","DOI":"10.1093\/crocol\/otz019","volume":"1","author":"A Chandrasekaran","year":"2019","unstructured":"Chandrasekaran A, Groven S, Lewis JD et al. An autoimmune protocol diet improves patient-reported quality of life in inflammatory bowel disease. Crohn\u2019s & Colitis 360 2019;1:otz019. https:\/\/doi.org\/10.1093\/crocol\/otz019.","journal-title":"Crohn\u2019s & Colitis 360"},{"key":"10049_CR37","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1097\/MIB.0000000000001221","volume":"23","author":"GG Konijeti","year":"2017","unstructured":"Konijeti GG, Kim N, Lewis JD et al. Efficacy of the autoimmune protocol diet for inflammatory bowel disease. Inflammatory Bowel Diseases 2017;23:2054\u20132060. https:\/\/doi.org\/10.1097\/MIB.0000000000001221.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR38","unstructured":"Eswaran S. Low-FODMAP (Fermentable, Oligo-, Di-, Mono-saccharides and Polyols) diet: Overview. American College of Gastroenterology. Retrieved February 5, 2025, from https:\/\/gi.org\/topics\/low-fodmap-diet\/#tabs2"},{"key":"10049_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.crohns.2008.09.004","volume":"3","author":"RB Gearry","year":"2009","unstructured":"Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease\u2014a pilot study. Journal of Crohn\u2019s and Colitis 2009;3:8\u201314. https:\/\/doi.org\/10.1016\/j.crohns.2008.09.004.","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10049_CR40","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/MIB.0000000000000708","volume":"22","author":"AC Prince","year":"2016","unstructured":"Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2016;22:1129\u20131136. https:\/\/doi.org\/10.1097\/MIB.0000000000000708.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR41","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.3748\/wjg.v23.i18.3356","volume":"23","author":"N Pedersen","year":"2017","unstructured":"Pedersen N, Ankersen DV, Felding M et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World Journal of Gastroenterology 2017;23:3356\u20133366. https:\/\/doi.org\/10.3748\/wjg.v23.i18.3356.","journal-title":"World Journal of Gastroenterology"},{"key":"10049_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/j.gastro.2019.09.024","volume":"158","author":"SR Cox","year":"2020","unstructured":"Cox SR, Lindsay JO, Fromentin S et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology 2020;158:176-188.e7. https:\/\/doi.org\/10.1053\/j.gastro.2019.09.024.","journal-title":"Gastroenterology"},{"key":"10049_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2019.06.023","volume":"67\u201368","author":"G Bodini","year":"2019","unstructured":"Bodini G, Zanella C, Crespi M et al. A randomized, 6-week trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutrition 2019;67\u201368:110542. https:\/\/doi.org\/10.1016\/j.nut.2019.06.023.","journal-title":"Nutrition"},{"key":"10049_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cgh.2018.08.001","volume":"17","author":"JF Colombel","year":"2019","unstructured":"Colombel JF, Shin A, Gibson PR. AGA clinical practice update on functional gastrointestinal symptoms in patients with inflammatory bowel disease: Expert review. Clinical Gastroenterology and Hepatology 2019;17:380-390.e1. https:\/\/doi.org\/10.1016\/j.cgh.2018.08.001.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR45","first-page":"1148","volume":"92","author":"B Mishkin","year":"1997","unstructured":"Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn\u2019s disease patients at low risk for lactose malabsorption based on ethnic origin. American Journal of Gastroenterology 1997;92:1148\u20131153.","journal-title":"American Journal of Gastroenterology"},{"key":"10049_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00042737-200012010-00003","volume":"12","author":"E Capristo","year":"2000","unstructured":"Capristo E, Mingrone G, Addolorato G, Greco AV, Gasbarrini G. Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn\u2019s disease. European Journal of Gastroenterology & Hepatology 2000;12:5\u201311. https:\/\/doi.org\/10.1097\/00042737-200012010-00003.","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10049_CR47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rgmx.2012.07.011","volume":"77","author":"GA Cabrera-Acosta","year":"2012","unstructured":"Cabrera-Acosta GA, Milke-Garc\u00eda MP, Ram\u00edrez-Iglesias MT, Uscanga L. Deficient lactose digestion and intolerance in a group of patients with chronic nonspecific ulcerative colitis: A controlled, double-blind, cross-over clinical trial. Revista de Gastroenterolog\u00eda de M\u00e9xico 2012;77:26\u201330.","journal-title":"Revista de Gastroenterolog\u00eda de M\u00e9xico"},{"key":"10049_CR48","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/nu15071615","volume":"15","author":"S Cenni","year":"2023","unstructured":"Cenni S, Sesenna V, Boiardi G et al. The role of gluten in gastrointestinal disorders: A review. Nutrients 2023;15:1615. https:\/\/doi.org\/10.3390\/nu15071615.","journal-title":"Nutrients"},{"key":"10049_CR49","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/MIB.0000000000000077","volume":"20","author":"HH Herfarth","year":"2014","unstructured":"Herfarth HH, Martin CF, Sandler RS, Kappelman MD, Long MD. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflammatory Bowel Diseases 2014;20:1194\u20131197. https:\/\/doi.org\/10.1097\/MIB.0000000000000077.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR50","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/MIB.0000000000000335","volume":"21","author":"I Aziz","year":"2015","unstructured":"Aziz I, Branchi F, Pearson K, Priest J, Sanders DS. A study evaluating the bidirectional relationship between inflammatory bowel disease and self-reported non-celiac gluten sensitivity. Inflammatory Bowel Diseases 2015;21:847\u2013853. https:\/\/doi.org\/10.1097\/MIB.0000000000000335.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/00365521.2017.1409364","volume":"53","author":"BN Limketkai","year":"2018","unstructured":"Limketkai BN, Sepulveda R, Hing T et al. Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2018;53:147\u2013151. https:\/\/doi.org\/10.1080\/00365521.2017.1409364.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10049_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajg.2024.01.009","volume":"26","author":"F Alborzi Avanaki","year":"2025","unstructured":"Alborzi Avanaki F, Ebrahimi Daryani N, Aletaha N, Hesabgar N, Rezaee-Zavareh MS, Hadi R. Short-term effect of gluten-free diet on disease severity, quality of life, and inflammatory markers among patients with mild to moderate ulcerative colitis: A triple-blind randomized placebo-controlled trial. Arab Journal of Gastroenterology 2025;26:18\u201322. https:\/\/doi.org\/10.1016\/j.ajg.2024.01.009.","journal-title":"Arab Journal of Gastroenterology"},{"key":"10049_CR53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ncp.10960","volume":"38","author":"A Church","year":"2023","unstructured":"Church A, Zoeller S. Enteral nutrition product formulations: A review of available products and indications for use. Nutrition in Clinical Practice 2023;38:277\u2013300. https:\/\/doi.org\/10.1002\/ncp.10960.","journal-title":"Nutrition in Clinical Practice"},{"key":"10049_CR54","unstructured":"Issokson K, Vasiliauskas E. Exclusive enteral nutrition in inflammatory bowel disease: An under-appreciated therapeutic gem. Practical Gastroenterology 2023; 47(1), Nutrition Reviews in Gastroenterology, Series #1."},{"key":"10049_CR55","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3390\/nu16213581","volume":"16","author":"R Geesala","year":"2024","unstructured":"Geesala R, Gongloor P, Recharla N, Shi XZ. Mechanisms of action of exclusive enteral nutrition and other nutritional therapies in Crohn\u2019s disease. Nutrients 2024;16:3581. https:\/\/doi.org\/10.3390\/nu16213581.","journal-title":"Nutrients"},{"key":"10049_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12519-018-0204-0","volume":"15","author":"Y Yu","year":"2019","unstructured":"Yu Y, Chen KC, Chen J. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn\u2019s disease: A meta-analysis. World Journal of Pediatrics 2019;15:26\u201336. https:\/\/doi.org\/10.1007\/s12519-018-0204-0.","journal-title":"World Journal of Pediatrics"},{"key":"10049_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clnu.2018.01.020","volume":"38","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Gavin J, Beattie RM. Exclusive enteral nutrition in Crohn\u2019s disease: Evidence and practicalities. Clinical Nutrition 2019;38:80\u201389. https:\/\/doi.org\/10.1016\/j.clnu.2018.01.020.","journal-title":"Clinical Nutrition"},{"key":"10049_CR58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ibd.21690","volume":"18","author":"JL Grogan","year":"2012","unstructured":"Grogan JL, Casson DH, Terry A, Burdge GC, El-Matary W, Dalzell AM. Enteral feeding therapy for newly diagnosed pediatric Crohn\u2019s disease: A double-blind randomized controlled trial with two years follow-up. Inflammatory Bowel Diseases 2012;18:246\u2013253. https:\/\/doi.org\/10.1002\/ibd.21690.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR59","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1651-2227.2004.tb02956.x","volume":"93","author":"JF Ludvigsson","year":"2004","unstructured":"Ludvigsson JF, Krantz M, Bodin L, Stenhammar L, Lindquist B. Elemental versus polymeric enteral nutrition in paediatric Crohn\u2019s disease: A multicentre randomized controlled trial. Acta Paediatrica 2004;93:327\u2013335.","journal-title":"Acta Paediatrica"},{"key":"10049_CR60","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/ibd\/izac215","volume":"29","author":"M Cuomo","year":"2023","unstructured":"Cuomo M, Carobbio A, Aloi M et al. Induction of remission with exclusive enteral nutrition in children with Crohn\u2019s disease: Determinants of higher adherence and response. Inflammatory Bowel Diseases 2023;29:1380\u20131389. https:\/\/doi.org\/10.1093\/ibd\/izac215.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/CEG.S267172","volume":"14","author":"R de Sire","year":"2021","unstructured":"de Sire R, Nardone OM, Testa A, Calabrese G, Caiazzo A, Castiglione F. Exclusive enteral nutrition in adult Crohn\u2019s disease: An overview of clinical practice and perceived barriers. Clinical and Experimental Gastroenterology 2021;14:493\u2013501. https:\/\/doi.org\/10.2147\/CEG.S267172.","journal-title":"Clinical and Experimental Gastroenterology"},{"key":"10049_CR62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jhn.12829","volume":"34","author":"RN Mutsekwa","year":"2021","unstructured":"Mutsekwa RN, Edwards JT, Angus RL. Exclusive enteral nutrition in the management of Crohn\u2019s disease: A qualitative exploration of experiences, challenges and enablers in adult patients. Journal of Human Nutrition and Dietetics 2021;34:440\u2013449. https:\/\/doi.org\/10.1111\/jhn.12829.","journal-title":"Journal of Human Nutrition and Dietetics"},{"key":"10049_CR63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijsu.2019.03.012","volume":"65","author":"X Ge","year":"2019","unstructured":"Ge X, Tang S, Yang X et al. The role of exclusive enteral nutrition in the preoperative optimization of laparoscopic surgery for patients with Crohn\u2019s disease: A cohort study. International Journal of Surgery 2019;65:39\u201344. https:\/\/doi.org\/10.1016\/j.ijsu.2019.03.012.","journal-title":"International Journal of Surgery"},{"key":"10049_CR64","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/apt.13934","volume":"45","author":"N Heerasing","year":"2017","unstructured":"Heerasing N, Thompson B, Hendy P et al. Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn\u2019s disease. Alimentary Pharmacology & Therapeutics 2017;45:660\u2013669. https:\/\/doi.org\/10.1111\/apt.13934.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR65","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/apt.16249","volume":"53","author":"P Sahu","year":"2021","unstructured":"Sahu P, Kedia S, Vuyyuru SK et al. Randomised clinical trial: Exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis. Alimentary Pharmacology & Therapeutics 2021;53:568\u2013576. https:\/\/doi.org\/10.1111\/apt.16249.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR66","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/gut.2004.062554","volume":"55","author":"T Johnson","year":"2006","unstructured":"Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn\u2019s disease in children using partial enteral nutrition with liquid formula: A randomised controlled trial. Gut 2006;55:356\u2013361. https:\/\/doi.org\/10.1136\/gut.2004.062554.","journal-title":"Gut"},{"key":"10049_CR67","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1365-2036.2006.03120.x","volume":"24","author":"S Takagi","year":"2006","unstructured":"Takagi S, Utsunomiya K, Kuriyama S et al. Effectiveness of a \u2018half elemental diet\u2019 as maintenance therapy for Crohn\u2019s disease: A randomized controlled trial. Alimentary Pharmacology & Therapeutics 2006;24:1333\u20131340. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03120.x.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR68","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.4103\/njcp.njcp_563_24","volume":"27","author":"S Liao","year":"2024","unstructured":"Liao S, Wang B, Zheng Z, Ye S, Huang L, Zheng Y. Therapeutic value of exclusive and partial enteral nutrition in adult patients with moderate to severe Crohn\u2019s disease with ustekinumab for induction of remission. Nigerian Journal of Clinical Practice 2024;27:1399\u20131404. https:\/\/doi.org\/10.4103\/njcp.njcp_563_24.","journal-title":"Nigerian Journal of Clinical Practice"},{"key":"10049_CR69","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00431-019-03520-7","volume":"179","author":"D Urlep","year":"2020","unstructured":"Urlep D, Benedik E, Brecelj J, Orel R. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn\u2019s disease: Results of a prospective cohort study. European Journal of Pediatrics 2020;179:431\u2013438. https:\/\/doi.org\/10.1007\/s00431-019-03520-7.","journal-title":"European Journal of Pediatrics"},{"key":"10049_CR70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/gut.27.5.481","volume":"27","author":"PB McIntyre","year":"1986","unstructured":"McIntyre PB, Powell-Tuck J, Wood SR et al. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986;27:481\u2013485. https:\/\/doi.org\/10.1136\/gut.27.5.481.","journal-title":"Gut"},{"key":"10049_CR71","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1017\/S0007114524001247","volume":"132","author":"Z Sun","year":"2024","unstructured":"Sun Z, Cao L, Chen Y et al. Impact of total parenteral nutrition. British Journal of Nutrition 2024;132:382\u2013391. https:\/\/doi.org\/10.1017\/S0007114524001247.","journal-title":"British Journal of Nutrition"},{"key":"10049_CR72","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology 2017;14:491\u2013502. https:\/\/doi.org\/10.1038\/nrgastro.2017.75.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10049_CR73","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3748\/wjg.v29.i14.2078","volume":"29","author":"S Roy","year":"2023","unstructured":"Roy S, Dhaneshwar S. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. World Journal of Gastroenterology 2023;29:2078\u20132100. https:\/\/doi.org\/10.3748\/wjg.v29.i14.2078.","journal-title":"World Journal of Gastroenterology"},{"key":"10049_CR74","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/nu12030859","volume":"12","author":"MCW Myhrstad","year":"2020","unstructured":"Myhrstad MCW, Tunsj\u00f8 H, Charnock C, Telle-Hansen VH. Dietary fiber, gut microbiota, and metabolic regulation\u2014Current status in human randomized trials. Nutrients 2020;12:859. https:\/\/doi.org\/10.3390\/nu12030859.","journal-title":"Nutrients"},{"key":"10049_CR75","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki K, Deehan EC, Walter J, B\u00e4ckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host & Microbe 2018;23:705\u2013715. https:\/\/doi.org\/10.1016\/j.chom.2018.05.012.","journal-title":"Cell Host & Microbe"},{"key":"10049_CR76","doi-asserted-by":"publisher","first-page":"1348886","DOI":"10.1080\/16512235.2017.1348886","volume":"28","author":"\u00d6 Umu","year":"2017","unstructured":"Umu \u00d6, Rudi K, Diep DB. Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microbial Ecology in Health and Disease 2017;28:1348886. https:\/\/doi.org\/10.1080\/16512235.2017.1348886.","journal-title":"Microbial Ecology in Health and Disease"},{"key":"10049_CR77","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3109\/00365529108998594","volume":"26","author":"C Hallert","year":"1991","unstructured":"Hallert C, Kaldma M, Petersson BG. Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. Scandinavian Journal of Gastroenterology 1991;26:747\u2013750. https:\/\/doi.org\/10.3109\/00365529108998594.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10049_CR78","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1572-0241.1999.872_a.x","volume":"94","author":"F Fern\u00e1ndez-Ba\u00f1ares","year":"1999","unstructured":"Fern\u00e1ndez-Ba\u00f1ares F, Hinojosa J, S\u00e1nchez-Lombra\u00f1a JL et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn\u2019s Disease and Ulcerative Colitis (GETECCU). American Journal of Gastroenterology 1999;94:427\u2013433. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.872_a.x.","journal-title":"American Journal of Gastroenterology"},{"key":"10049_CR79","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1365-2036.2007.03288.x","volume":"25","author":"F Casellas","year":"2007","unstructured":"Casellas F, Borruel N, Torrej\u00f3n A et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Alimentary Pharmacology & Therapeutics 2007;25:1061\u20131067. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03288.x.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR80","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10350-004-6257-2","volume":"45","author":"CF Welters","year":"2002","unstructured":"Welters CF, Heineman E, Thunnissen FB, van den Bogaard AE, Soeters PB, Baeten CG. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Diseases of the Colon & Rectum 2002;45:621\u2013627. https:\/\/doi.org\/10.1007\/s10350-004-6257-2.","journal-title":"Diseases of the Colon & Rectum"},{"key":"10049_CR81","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/gut.2005.074971","volume":"55","author":"JO Lindsay","year":"2006","unstructured":"Lindsay JO, Whelan K, Stagg AJ et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn\u2019s disease. Gut 2006;55:348\u2013355. https:\/\/doi.org\/10.1136\/gut.2005.074971.","journal-title":"Gut"},{"key":"10049_CR82","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2010.232025","volume":"60","author":"JL Benjamin","year":"2011","unstructured":"Benjamin JL, Hedin CR, Koutsoumpas A et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn\u2019s disease. Gut 2011;60:923\u2013929. https:\/\/doi.org\/10.1136\/gut.2010.232025.","journal-title":"Gut"},{"key":"10049_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae115","volume-title":"Prebiotics for induction and maintenance of remission in inflammatory bowel disease: Systematic review and meta-analysis","author":"BN Limketkai","year":"2024","unstructured":"Limketkai BN, Godoy-Brewer G, Shah ND et al. Prebiotics for induction and maintenance of remission in inflammatory bowel disease: Systematic review and meta-analysis. Inflammatory Bowel Diseases: Advance online publication; 2024. https:\/\/doi.org\/10.1093\/ibd\/izae115."},{"key":"10049_CR84","doi-asserted-by":"publisher","first-page":"G1025","DOI":"10.1152\/ajpgi.90227.2008","volume":"295","author":"JB Ewaschuk","year":"2008","unstructured":"Ewaschuk JB, Diaz H, Meddings L et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008;295:G1025\u2013G1034. https:\/\/doi.org\/10.1152\/ajpgi.90227.2008.","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"10049_CR85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00281-014-0454-4","volume":"37","author":"K Matsuoka","year":"2015","unstructured":"Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Seminars in Immunopathology 2015;37:47\u201355. https:\/\/doi.org\/10.1007\/s00281-014-0454-4.","journal-title":"Seminars in Immunopathology"},{"key":"10049_CR86","doi-asserted-by":"publisher","first-page":"G807","DOI":"10.1152\/ajpgi.00243.2009","volume":"298","author":"CL Ohland","year":"2010","unstructured":"Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010;298:G807\u2013G819. https:\/\/doi.org\/10.1152\/ajpgi.00243.2009.","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"10049_CR87","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/CEG.S27530","volume":"7","author":"YA Ghouri","year":"2014","unstructured":"Ghouri YA, Richards DM, Rahimi EF, Krill JT, Jelinek KA, DuPont AW. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clinical and Experimental Gastroenterology 2014;7:473\u2013487. https:\/\/doi.org\/10.2147\/CEG.S27530.","journal-title":"Clinical and Experimental Gastroenterology"},{"key":"10049_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6882-10-13","volume":"10","author":"H Matthes","year":"2010","unstructured":"Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J. Clinical trial: Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complementary and Alternative Medicine 2010;10:13. https:\/\/doi.org\/10.1186\/1472-6882-10-13.","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10049_CR89","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","volume":"11","author":"W Kruis","year":"1997","unstructured":"Kruis W, Sch\u00fctz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Alimentary Pharmacology & Therapeutics 1997;11:853\u2013858. https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00225.x.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR90","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2003.037747","volume":"53","author":"W Kruis","year":"2004","unstructured":"Kruis W, Fric P, Pokrotnieks J et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004;53:1617\u20131623. https:\/\/doi.org\/10.1136\/gut.2003.037747.","journal-title":"Gut"},{"key":"10049_CR91","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","volume":"100","author":"R Bibiloni","year":"2005","unstructured":"Bibiloni R, Fedorak RN, Tannock GW et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. American Journal of Gastroenterology 2005;100:1539\u20131546. https:\/\/doi.org\/10.1111\/j.1572-0241.2005.41794.x.","journal-title":"American Journal of Gastroenterology"},{"key":"10049_CR92","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/MIB.0000000000000084","volume":"20","author":"HE Mardini","year":"2014","unstructured":"Mardini HE, Grigorian AY. Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: A meta-analysis. Inflammatory Bowel Diseases 2014;20:1562\u20131567. https:\/\/doi.org\/10.1097\/MIB.0000000000000084.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR93","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ajg.2008.118","volume":"104","author":"E Miele","year":"2009","unstructured":"Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. American Journal of Gastroenterology 2009;104:437\u2013443. https:\/\/doi.org\/10.1038\/ajg.2008.118.","journal-title":"American Journal of Gastroenterology"},{"key":"10049_CR94","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1046\/j.1365-2036.1999.00560.x","volume":"13","author":"A Venturi","year":"1999","unstructured":"Venturi A, Gionchetti P, Rizzello F et al. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics 1999;13:1103\u20131108. https:\/\/doi.org\/10.1046\/j.1365-2036.1999.00560.x.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR95","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gut.53.1.108","volume":"53","author":"T Mimura","year":"2004","unstructured":"Mimura T, Rizzello F, Helwig U et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108\u2013114. https:\/\/doi.org\/10.1136\/gut.53.1.108.","journal-title":"Gut"},{"key":"10049_CR96","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cgh.2013.02.021","volume":"11","author":"A Bourreille","year":"2013","unstructured":"Bourreille A, Cadiot G, Le Dreau G et al. Saccharomyces boulardii does not prevent relapse of Crohn\u2019s disease. Clinical Gastroenterology and Hepatology 2013;11:982\u2013987. https:\/\/doi.org\/10.1016\/j.cgh.2013.02.021.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR97","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/apt.14203","volume":"46","author":"Y Derwa","year":"2017","unstructured":"Derwa Y, Gracie DJ, Hamlin PJ, Ford AC. Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2017;46:389\u2013400. https:\/\/doi.org\/10.1111\/apt.14203.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR98","doi-asserted-by":"publisher","first-page":"CD005573","DOI":"10.1002\/14651858.CD005573.pub3","volume":"2020","author":"L Kaur","year":"2020","unstructured":"Kaur L, Gordon M, Baines PA, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK. Probiotics for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2020;2020:CD005573. https:\/\/doi.org\/10.1002\/14651858.CD005573.pub3.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10049_CR99","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","volume":"159","author":"GL Su","year":"2020","unstructured":"Su GL, Ko CW, Bercik P, Falck-Ytter Y, Sultan S, Weizman AV, Morgan RL. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology 2020;159:697\u2013705. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.059.","journal-title":"Gastroenterology"},{"key":"10049_CR100","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/ajg.2016.47","volume":"111","author":"AN Ananthakrishnan","year":"2016","unstructured":"Ananthakrishnan AN. Editorial: Vitamin D and IBD: Can we get over the \u201ccausation\u201d hump? American Journal of Gastroenterology 2016;111:720\u2013722. https:\/\/doi.org\/10.1038\/ajg.2016.47.","journal-title":"American Journal of Gastroenterology"},{"key":"10049_CR101","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1542\/peds.2006-0841","volume":"118","author":"HM Pappa","year":"2006","unstructured":"Pappa HM, Gordon CM, Saslowsky TM et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006;118:1950\u20131961. https:\/\/doi.org\/10.1542\/peds.2006-0841.","journal-title":"Pediatrics"},{"key":"10049_CR102","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2016.02.011","volume":"166\u2013167","author":"L Fawaz","year":"2016","unstructured":"Fawaz L, Mrad MF, Kazan JM, Sayegh S, Akika R, Khoury SJ. Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation. Clinical Immunology 2016;166\u2013167:59\u201371. https:\/\/doi.org\/10.1016\/j.clim.2016.02.011.","journal-title":"Clinical Immunology"},{"key":"10049_CR103","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1097\/MCG.0000000000001112","volume":"52","author":"M Miraglia Del Giudice","year":"2018","unstructured":"Miraglia Del Giudice M, Indolfi C, Strisciuglio C. Vitamin D: Immunomodulatory aspects. Journal of Clinical Gastroenterology 2018;52:S86\u2013S88. https:\/\/doi.org\/10.1097\/MCG.0000000000001112.","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10049_CR104","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2011.11.040","volume":"142","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan AN, Khalili H, Higuchi LM et al. Higher predicted vitamin D status is associated with reduced risk of Crohn\u2019s disease. Gastroenterology 2012;142:482\u2013489. https:\/\/doi.org\/10.1053\/j.gastro.2011.11.040.","journal-title":"Gastroenterology"},{"key":"10049_CR105","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1097\/MIB.0b013e3182902ad9","volume":"19","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, Cagan A, Gainer VS et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn\u2019s disease. Inflammatory Bowel Diseases 2013;19:1921\u20131927. https:\/\/doi.org\/10.1097\/MIB.0b013e3182902ad9.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR106","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2036.2010.04355.x","volume":"32","author":"SP J\u00f8rgensen","year":"2010","unstructured":"J\u00f8rgensen SP, Agnholt J, Glerup H et al. Clinical trial: Vitamin D3 treatment in Crohn\u2019s disease\u2014a randomized double-blind placebo-controlled study. Alimentary Pharmacology & Therapeutics 2010;32:377\u2013383. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04355.x.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10049_CR107","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s10620-016-4396-7","volume":"62","author":"N Narula","year":"2017","unstructured":"Narula N, Cooray M, Anglin R, Muqtadir Z, Narula A, Marshall JK. Impact of high-dose vitamin D3 supplementation in patients with Crohn\u2019s disease in remission: A pilot randomized double-blind controlled study. Digestive Diseases and Sciences 2017;62:448\u2013455. https:\/\/doi.org\/10.1007\/s10620-016-4396-7.","journal-title":"Digestive Diseases and Sciences"},{"key":"10049_CR108","doi-asserted-by":"publisher","first-page":"CD011806","DOI":"10.1002\/14651858.CD011806.pub2","volume":"2023","author":"C Wallace","year":"2023","unstructured":"Wallace C, Gordon M, Sinopoulou V, Limketkai BN. Vitamin D for the treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews 2023;2023:CD011806. https:\/\/doi.org\/10.1002\/14651858.CD011806.pub2.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10049_CR109","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/00054725-200608000-00016","volume":"12","author":"GR Lichtenstein","year":"2006","unstructured":"Lichtenstein GR, Sands BE, Pazianas M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflammatory Bowel Diseases 2006;12:797\u2013813. https:\/\/doi.org\/10.1097\/00054725-200608000-00016.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR110","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","volume":"21","author":"AP Simopoulos","year":"2002","unstructured":"Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition 2002;21:495\u2013505. https:\/\/doi.org\/10.1080\/07315724.2002.10719248.","journal-title":"Journal of the American College of Nutrition"},{"key":"10049_CR111","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7326\/0003-4819-116-8-609","volume":"116","author":"WF Stenson","year":"1992","unstructured":"Stenson WF, Cort D, Rodgers J et al. Dietary supplementation with fish oil in ulcerative colitis. Annals of Internal Medicine 1992;116:609\u2013614. https:\/\/doi.org\/10.7326\/0003-4819-116-8-609.","journal-title":"Annals of Internal Medicine"},{"key":"10049_CR112","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/gut.33.7.922","volume":"33","author":"AB Hawthorne","year":"1992","unstructured":"Hawthorne AB, Daneshmend TK, Hawkey CJ et al. Treatment of ulcerative colitis with fish oil supplementation: A prospective 12-month randomised controlled trial. Gut 1992;33:922\u2013928. https:\/\/doi.org\/10.1136\/gut.33.7.922.","journal-title":"Gut"},{"key":"10049_CR113","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/BF02093614","volume":"41","author":"K Loeschke","year":"1996","unstructured":"Loeschke K, Ueberschaer B, Pietsch A et al. n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Digestive Diseases and Sciences 1996;41:2087\u20132094. https:\/\/doi.org\/10.1007\/BF02093614.","journal-title":"Digestive Diseases and Sciences"},{"key":"10049_CR114","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.299.14.1690","volume":"299","author":"BG Feagan","year":"2008","unstructured":"Feagan BG, Sandborn WJ, Mittmann U et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: The EPIC randomized controlled trials. JAMA 2008;299:1690\u20131697. https:\/\/doi.org\/10.1001\/jama.299.14.1690.","journal-title":"JAMA"},{"key":"10049_CR115","doi-asserted-by":"publisher","first-page":"1217165","DOI":"10.3389\/fendo.2023.1217165","volume":"14","author":"DK Sahoo","year":"2023","unstructured":"Sahoo DK, Heilmann RM, Paital B et al. Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Frontiers in Endocrinology 2023;14:1217165. https:\/\/doi.org\/10.3389\/fendo.2023.1217165.","journal-title":"Frontiers in Endocrinology"},{"key":"10049_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.908077","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Liu H, Bu L, Chen C, Ye X. Review of the effects and mechanism of curcumin in the treatment of inflammatory bowel disease. Frontiers in Pharmacology 2022;13:908077. https:\/\/doi.org\/10.3389\/fphar.2022.908077.","journal-title":"Frontiers in Pharmacology"},{"key":"10049_CR117","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s10620-005-3032-8","volume":"50","author":"PR Holt","year":"2005","unstructured":"Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: A pilot study. Digestive Diseases and Sciences 2005;50:2191\u20132193. https:\/\/doi.org\/10.1007\/s10620-005-3032-8.","journal-title":"Digestive Diseases and Sciences"},{"key":"10049_CR118","doi-asserted-by":"publisher","first-page":"9552","DOI":"10.1002\/jcb.27273","volume":"119","author":"M Masoodi","year":"2018","unstructured":"Masoodi M, Mahdiabadi MA, Mokhtare M et al. The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients\u2019 self-reported well-being: A randomized double-blind controlled trial. Journal of Cellular Biochemistry 2018;119:9552\u20139559. https:\/\/doi.org\/10.1002\/jcb.27273.","journal-title":"Journal of Cellular Biochemistry"},{"key":"10049_CR119","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.cgh.2006.08.008","volume":"4","author":"H Hanai","year":"2006","unstructured":"Hanai H, Iida T, Takeuchi K et al. Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology 2006;4:1502\u20131506. https:\/\/doi.org\/10.1016\/j.cgh.2006.08.008.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR120","doi-asserted-by":"publisher","first-page":"1411566","DOI":"10.3389\/fphar.2024.1411566","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu Y, Lou Y, Zhou Z et al. Resveratrol for inflammatory bowel disease in preclinical studies: A systematic review and meta-analysis. Frontiers in Pharmacology 2024;15:1411566. https:\/\/doi.org\/10.3389\/fphar.2024.1411566.","journal-title":"Frontiers in Pharmacology"},{"key":"10049_CR121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.arcmed.2015.05.005","volume":"46","author":"M Samsami-Kor","year":"2015","unstructured":"Samsami-Kor M, Daryani NE, Asl PR, Hekmatdoost A. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study. Archives of Medical Research 2015;46:280\u2013285. https:\/\/doi.org\/10.1016\/j.arcmed.2015.05.005.","journal-title":"Archives of Medical Research"},{"key":"10049_CR122","first-page":"210","volume":"28","author":"A Triantafyllidi","year":"2015","unstructured":"Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis JK. Herbal and plant therapy in patients with inflammatory bowel disease. Annals of Gastroenterology 2015;28:210\u2013220.","journal-title":"Annals of Gastroenterology"},{"key":"10049_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2021.105650","volume":"167","author":"AS Day","year":"2021","unstructured":"Day AS, Yao CK, Costello SP, Andrews JM, Bryant RV. Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite 2021;167:105650. https:\/\/doi.org\/10.1016\/j.appet.2021.105650.","journal-title":"Appetite"},{"key":"10049_CR124","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cgh.2021.08.009","volume":"20","author":"E Yelencich","year":"2022","unstructured":"Yelencich E, Truong E, Widaman AM et al. Avoidant restrictive food intake disorder prevalent among patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2022;20:1282-1289.e1. https:\/\/doi.org\/10.1016\/j.cgh.2021.08.009.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR125","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cgh.2021.07.045","volume":"20","author":"M Fink","year":"2022","unstructured":"Fink M, Simons M, Tomasino K, Pandit A, Taft T. When is patient behavior indicative of avoidant restrictive food intake disorder (ARFID) vs reasonable response to digestive disease? Clinical Gastroenterology and Hepatology 2022;20:1241\u20131250. https:\/\/doi.org\/10.1016\/j.cgh.2021.07.045.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2021.105808","volume":"169","author":"HF Zickgraf","year":"2022","unstructured":"Zickgraf HF, Loftus P, Gibbons B, Cohen LC, Hunt MG. \u201cIf I could survive without eating, it would be a huge relief\u201d: Development and initial validation of the Fear of Food Questionnaire. Appetite 2022;169:105808. https:\/\/doi.org\/10.1016\/j.appet.2021.105808.","journal-title":"Appetite"},{"key":"10049_CR127","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s11136-019-02170-4","volume":"28","author":"L Guadagnoli","year":"2019","unstructured":"Guadagnoli L, Mutlu EA, Doerfler B, Ibrahim A, Brenner D, Taft TH. Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. Quality of Life Research 2019;28:2195\u20132205. https:\/\/doi.org\/10.1007\/s11136-019-02170-4.","journal-title":"Quality of Life Research"},{"key":"10049_CR128","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/ecco-jcc\/jjv192","volume":"10","author":"LD Hughes","year":"2016","unstructured":"Hughes LD, King L, Morgan M et al. Food-related quality of life in inflammatory bowel disease: Development and validation of a questionnaire. Journal of Crohn\u2019s and Colitis 2016;10:194\u2013201. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv192.","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"10049_CR129","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jhn.12920","volume":"35","author":"AS Day","year":"2022","unstructured":"Day AS, Yao CK, Costello SP, Andrews JM, Bryant RV. Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study. Journal of Human Nutrition and Dietetics 2022;35:234\u2013244. https:\/\/doi.org\/10.1111\/jhn.12920.","journal-title":"Journal of Human Nutrition and Dietetics"},{"key":"10049_CR130","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/ibd\/izac010","volume":"28","author":"SC Brown","year":"2022","unstructured":"Brown SC, Whelan K, Frampton C, Wall CL, Gearry RB, Day AS. Food-related quality of life in children and adolescents with Crohn\u2019s disease. Inflammatory Bowel Diseases 2022;28:1838\u20131843. https:\/\/doi.org\/10.1093\/ibd\/izac010.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10049_CR131","unstructured":"Rabbitt M, Hales L, Reed-Jones M. Food security in the U.S.\u2014Definitions of food security. U.S. Department of Agriculture, Economic Research Service. Accessed February 7, 2025."},{"key":"10049_CR132","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.cgh.2020.05.056","volume":"19","author":"NH Nguyen","year":"2021","unstructured":"Nguyen NH, Khera R, Ohno-Machado L, Sandborn WJ, Singh S. Prevalence and effects of food insecurity and social support on financial toxicity and healthcare use by patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology 2021;19:1377-1386.e5. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.056.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10049_CR133","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.3390\/nu16213736","volume":"16","author":"SL Gold","year":"2024","unstructured":"Gold SL, Kohler D, Freid H, Haskey N, Raman M. Food insecurity is common in patients with inflammatory bowel disease and is associated with increased ultra-processed food intake. Nutrients 2024;16:3736. https:\/\/doi.org\/10.3390\/nu16213736.","journal-title":"Nutrients"},{"key":"10049_CR134","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0002-8223(02)90247-6","volume":"102","author":"J Satia-Abouta","year":"2002","unstructured":"Satia-Abouta J, Patterson RE, Neuhouser ML, Elder J. Dietary acculturation: Applications to nutrition research and dietetics. Journal of the American Dietetic Association 2002;102:1105\u20131118. https:\/\/doi.org\/10.1016\/S0002-8223(02)90247-6.","journal-title":"Journal of the American Dietetic Association"},{"key":"10049_CR135","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.3390\/nu16183184","volume":"16","author":"R Sigall Boneh","year":"2024","unstructured":"Sigall Boneh R, Park S, Soledad Arcucci M et al. Cultural perspectives on the efficacy and adoption of the Crohn\u2019s disease exclusion diet across diverse ethnicities: A case-based overview. Nutrients 2024;16:3184. https:\/\/doi.org\/10.3390\/nu16183184.","journal-title":"Nutrients"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10049-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:03:03Z","timestamp":1789052583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10049-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":135,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10049"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10049-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author Neha D. Shah is a consultant for companies \u201cGI on Demand\u201d and \u201cGastro Girl.\u201d Authors Mark R. Baniqued, Alyssa M. Parian, and Jessica Dominguez have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}